The Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia

被引：2

作者：

Landau, Dan-Avi ^{[1
]}

Carter, Scott ^{[2
]}

Stojanov, Petar ^{[2
]}

Stevenson, Kristen E. ^{[3
]}

Mckenna, Aaron ^{[2
]}

Lawrence, Michael ^{[2
]}

Sougnez, Carrie ^{[2
]}

Sivachenko, Andrey ^{[2
]}

Wang, Lili ^{[1
]}

Mang, Wandi ^{[1
]}

Sachet, Shukla ^{[1
]}

Vartanov, Alexander R. ^{[1
]}

Fernandes, Stacey M. ^{[1
]}

Cibulskis, Kristian ^{[2
]}

Tesar, Bethany ^{[1
]}

Gabriel, Stacey ^{[2
]}

Meyerson, Matthew ^{[1
]}

Lander, Eric S. ^{[2
]}

Neuberg, Donna S. ^{[4
]}

Brown, Jennifer R. ^{[1
]}

Getz, Gad ^{[2
]}

Wu, Catherine J.

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[2] Broad Inst, Cambridge, MA USA

[3] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA

[4] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.5.5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 50 条

[1] Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
Landau, Dan A.
Carter, Scott L.
Stojanov, Petar
McKenna, Aaron
Stevenson, Kristen
Lawrence, Michael S.
Sougnez, Carrie
Stewart, Chip
Sivachenko, Andrey
Wang, Lili
Wan, Youzhong
Zhang, Wandi
Shukla, Sachet A.
Vartanov, Alexander
Fernandes, Stacey M.
Saksena, Gordon
Cibulskis, Kristian
Tesar, Bethany
Gabriel, Stacey
Hacohen, Nir
Meyerson, Matthew
Lander, Eric S.
Neuberg, Donna
Brown, Jennifer R.
Getz, Gad
Wu, Catherine J.
CELL, 2013, 152 (04) : 714 - 726
[2] Clinical Impact of Clonal and Subclonal TP53 Mutations in Chronic Lymphocytic Leukemia
Bomben, Riccardo
Rossi, Maria Francesca
D'Agaro, Tiziana
Bittolo, Tamara
Zucchetto, Antonella
Tissino, Erika
Pozzo, Federico
Vit, Filippo
Bulian, Pietro
Degan, Massimo
Zaina, Eva
Cattarossi, Ilaria
Nanni, Paola
Chivilo, Hillarj
D'Arena, Giovanni Francesco
Chiarenza, Annalisa
Santinelli, Enrico
Zaja, Francesco
Pozzato, Gabriele
Di Raimondo, Francesco
Del Poeta, Giovanni
Gattei, Valter
BLOOD, 2018, 132
[3] Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia
Schwaederle, M.
Ghia, E.
Rassenti, L. Z.
Obara, M.
Aquila, M. L. Dell'
Fecteau, J. F.
Kipps, T. J.
LEUKEMIA, 2013, 27 (05) : 1214 - 1217
[4] Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia
M Schwaederlé
E Ghia
L Z Rassenti
M Obara
M L Dell' Aquila
J F Fecteau
T J Kipps
Leukemia, 2013, 27 : 1214 - 1217
[5] Clinical Impact of the Quantitative Subclonal Architecture in Chronic Lymphocytic Leukemia
Nadeu, Ferran
Delgado, Julio
Clot, Guillem
Martin-Garcia, David
Baumann, Tycho
Pinyol, Magda
Jares, Pedro
Bea, Silvia
Salaverria, Itziar
Navarro, Alba
Suarez-Cisneros, Helena
Aymerich, Marta
Rozman, Maria
Villamor, Neus
Colomer, Dolors
Gonzalez, Marcos
Alcoceba, Miguel
Terol, Maria Jose
Colado, Enrique
Lopez-Guillermo, Armando
Puente, Xose S.
Lopez-Otin, Carlos
Enjuanes, Anna
Campo, Elias
BLOOD, 2016, 128 (22)
[6] Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
Nadeu, F.
Clot, G.
Delgado, J.
Martin-Garcia, D.
Baumann, T.
Salaverria, I.
Bea, S.
Pinyol, M.
Jares, P.
Navarro, A.
Suarez-Cisneros, H.
Aymerich, M.
Rozman, M.
Villamor, N.
Colomer, D.
Gonzalez, M.
Alcoceba, M.
Terol, M. J.
Navarro, B.
Colado, E.
Payer, A. R.
Puente, X. S.
Lopez-Otin, C.
Lopez-Guillermo, A.
Enjuanes, A.
Campo, E.
LEUKEMIA, 2018, 32 (03) : 645 - 653
[7] Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
F Nadeu
G Clot
J Delgado
D Martín-García
T Baumann
I Salaverria
S Beà
M Pinyol
P Jares
A Navarro
H Suárez-Cisneros
M Aymerich
M Rozman
N Villamor
D Colomer
M González
M Alcoceba
M J Terol
B Navarro
E Colado
ÁR Payer
X S Puente
C López-Otín
A López-Guillermo
A Enjuanes
E Campo
Leukemia, 2018, 32 : 645 - 653
[8] CLINICAL IMPACT OF THE SUBCLONAL ARCHITECTURE AND MUTATIONAL COMPLEXITY IN CHRONIC LYMPHOCYTIC LEUKEMIA
Nadeu, F.
Clot, G.
Delgado, J.
Martin-Garcia, D.
Baumann, T.
Salaverria, I.
Bea, S.
Pinyol, M.
Jares, P.
Navarro, A.
Suarez-Cisneros, H.
Aymerich, M.
Rozman, M.
Villamor, N.
Colomer, D.
Gonzalez, M.
Alcoceba, M.
Terol, M. J.
Navarro, B.
Colado, E.
Puente, X. S.
Lopez-Otin, C.
Lopez-Guillermo, A.
Enjuanes, A.
Campo, E.
HAEMATOLOGICA, 2017, 102 : 9 - 9
[9] Clinical Impact of Clonal and Subclonal TP53 Mutations and Deletions in Chronic Lymphocytic Leukemia: An Italian Multicenter Experience
Bomben, Riccardo
Rossi, Francesca Maria
D'Agaro, Tiziana
Bittolo, Tamara
Vit, Filippo
Zucchetto, Antonella
Tissino, Erika
Pozzo, Federico
Ballerini, Mario
Bulian, Pietro
Degan, Massimo
Polesel, Jerry
Zaina, Eva
Cattarossi, Ilaria
Nanni, Paola
Chivilo, Hillarj
D'Arena, Giovanni Francesco
Santinelli, Enrico
Biagi, Annalisa
Chiarenza, Annalisa
Zaja, Francesco
Pozzato, Gabriele
Di Raimondo, Francesco
Rossi, Davide
Del Poeta, Giovanni
Gattei, Valter
BLOOD, 2019, 134
[10] Clinical impact of clonal and subclonal TP53 mutations and deletions in chronic lymphocytic leukemia: an Italian multicenter experience
Bomben, Riccardo
Rossi, Francesca Maria
D'Agaro, Tiziana
Bittolo, Tamara
Vit, Filippo
Zucchetto, Antonella
Tissino, Erika
Pozzo, Federico
Bulian, Pietro
Degan, Massimo
Polesel, Jerry
D'Arena, Giovanni
Santinelli, Enrico
Biagi, Annalisa
Chiarenza, Annalisa
Zaja, Francesco
Pozzato, Gabriele
Di Raimondo, Francesco
Rossi, Davide
Del Poeta, Giovanni
Gattei, Valter
LEUKEMIA & LYMPHOMA, 2020, 61 : 215 - 217

← 1 2 3 4 5 →